PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma
Bron
Nature communications - ISSN 2041-1723-16:1 (2025) p. 1-21
Novel, rationally designed combination strategies, based on (phospho)proteomic analyses, to enhance the response to cetuximab therapy in head and neck cancer
Bron
Antwerpen, Universiteit Antwerpen, Faculteit Geneeskunde en Gezondheidswetenschappen, 2024,346 p.
De belofte van hoofdhalskankerorganoïden in kankeronderzoek : een blik op de toekomst
Bron
Onco-hemato : multidisciplinair tijdschrift voor oncologie - ISSN 2030-2738-17:7 (2023) p. 54-58
Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity
Bron
Cancer drug resistance - ISSN 2578-532X-6:4 (2023) p. 709-728
Co-targeting the EGFR and PI3K/Akt pathway to overcome therapeutic resistance in head and neck squamous cell carcinoma : what about autophagy?
Bron
Cancers - ISSN 2072-6694-14:24 (2022) p. 1-10